Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Letters

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.canlet.2011.12.028PMID 22198483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methyl jasmonate down‐regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL‐induced cytotoxicity

  2011cited by this paper
• Modulation of apoptosis by early human papillomavirus proteins in cervical cancer.

  2010cited by this paper
• Survivin and IAP proteins in cell-death mechanisms.

  2010cited by this paper
• Reactive oxygen species, cellular redox systems, and apoptosis.

  2010cited by this paper
• AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.

  2009cited by this paper
• Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells

  2009cited by this paper
• Methyl jasmonate: a plant stress hormone as an anti-cancer drug.

  2009cited by this paper
• Posttranslational modification of p53: cooperative integrators of function.

  2009cited by this paper
• Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms

  2008cited by this paper
• Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines

  2008cited by this paper
• Methyl jasmonate binds to and detaches mitochondria-bound hexokinase

  2008cited by this paper
• Delayed Cytotoxic Effects of Methyl Jasmonate and cis-Jasmone Induced Apoptosis in Prostate Cancer Cells

  2008cited by this paper
• Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells.

  2008cited by this paper
• Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.

  2007cited by this paper
• Jasmonates in cancer therapy.

  2007cited by this paper
• Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.

  2007cited by this paper
• Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family

  2007cited by this paper
• Cell death by necrosis: towards a molecular definition.

  2007cited by this paper
• Effects of human papillomavirus type 16 oncoproteins on survivin gene expression.

  2006cited by this paper
• Papillomaviruses as targets for cancer gene therapy

  2006cited by this paper
• Papillomaviruses as targets for cancer gene therapy.

  2006cited by this paper
• Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy.

  2006cited by this paper
• Human papillomaviruses and cervical cancer.

  2006cited by this paper
• Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosis

  2006cited by this paper
• Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

  2005cited by this paper
• Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.

  2005cited by this paper
• Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation.

  2005cited by this paper
• Chemotherapy in the primary treatment of cervical carcinoma.

  2005cited by this paper
• Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells.

  2004cited by this paper
• New drugs in the treatment of recurrent or metastatic cervical cancer.

  2003cited by this paper
• Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer.

  2003cited by this paper
• Apoptosis: the complex scenario for a silent cell death.

  2003cited by this paper
• Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells

  2002cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Global cancer statistics in the year 2000.

  2001cited by this paper
• Apoptosis signaling.

  2000cited by this paper
• Transcription-modulatory activities of differentially spliced cDNAs encoding the E2 protein of human papillomavirus type 16.

  1999cited by this paper
• HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes.

  1999cited by this paper
• Estimates of the worldwide mortality from 25 cancers in 1990

  1999cited by this paper
• Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

  1985cited by this paper

• “Methyl jasmonate: bridging plant defense mechanisms and human therapeutics”

  2025cites this paper
• EZH2 activates Wnt/β-catenin signaling in human uterine fibroids which is inhibited by the natural compound Methyl Jasmonate.

  2023cites this paper
• HPV-induced cancers: preclinical therapeutic advancements

  2021cites this paper
• Chemosensitizing effects of methyl jasmonate on paclitaxel-resistant androgen-dependent and independent prostate cancer cell lines

  2021cites this paper
• Chloroform fraction of Chaetomorpha brachygona, a marine green alga from Indian Sundarbans inducing autophagy in cervical cancer cells in vitro

  2020cites this paper
• Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer

  2020cites this paper
• Integrated Proteomics and Metabolomics Analysis Provides Insights into Ganoderic Acid Biosynthesis in Response to Methyl Jasmonate in Ganoderma Lucidum

  2019cites this paper
• EZH2 inhibition promotes methyl jasmonate-induced apoptosis of human colorectal cancer through the Wnt/β-catenin pathway.

  2018cites this paper
• An analytical GC-MS method to quantify methyl dihydrojasmonate in biocompatible oil-in-water microemulsions: physicochemical characterization and in vitro release studies

  2018cites this paper
• Methyl jasmonate: a phytohormone with potential for the treatment of inflammatory bowel diseases

  2018cites this paper
• Anti-Inflammatory and Antioxidant Actions of Methyl Jasmonate Are Associated with Metabolic Modifications in the Liver of Arthritic Rats

  2018cites this paper
• EZH 2 inhibition promotes methyl jasmonate ‐ induced apoptosis of human colorectal cancer through the Wnt / β ‐ catenin pathway

  2018cites this paper
• Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells

  2018cites this paper
• Susceptibility of epithelial tumour cell lines to hyperthermia

  2018cites this paper
• Possible role of nanocarriers in drug delivery against cervical cancer

  2017cites this paper
• Therapeutic action of curcumin loaded chitosan nanoparticles for cervical cancer

  2017cites this paper
• Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA‑101.

  2017cites this paper
• Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice.

  2017cites this paper
• Survivin and gynaecological tumours.

  2017cites this paper
• Synthesis of jasmonates and derivatives to study plant signaling: activation, translocation and shutdown mechanisms

  2016cites this paper
• Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.

  2016cites this paper
• Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.

  2016cites this paper
• P16INK4A and survivin: Diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinoma.

  2015cites this paper
• MiR-34a Inhibits Viability and Invasion of Human Papillomavirus–Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin

  2015cites this paper
• Oil-in-water biocompatible microemulsion as a carrier for the antitumor drug compound methyl dihydrojasmonate

  2015cites this paper
• Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer

  2015cites this paper
• Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication.

  2015cites this paper
• Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis

  2014cites this paper
• Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes.

  2014cites this paper
• IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.

  2014cites this paper
• Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14

  2013cites this paper
• Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo.

  2013cites this paper
• Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation

  2013influential citation
• The anti-cancer activities of jasmonates

  2013cites this paper
• DESENVOLVIMENTO E CARACTERIZAÇÃO FÍSICO-QUÍMICA E BIOFARMACÊUTICA DE NANO E MICROEMULSÕES LIPÍDICAS DE USO INTRAVENOSO CONTENDO METILDIIDROJASMONATO

  2013cites this paper
• Complementary and Alternative Medicine and Cancer Survivorship

  2012cites this paper
• Title Emerging glycolysis targeting and drug discovery from chinesemedicine in cancer therapy

  2012cites this paper
• Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy

  2012cites this paper